MKT Advisors’s iShares Biotechnology ETF IBB Stock Holding History

MKT Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,631	Closed	-$219K	–	148
2022 Q4	$219K	Buy	+1,631	New	+$211K	0.16%	121
2022 Q3	–	Sell	-1,631	Closed	-$203K	–	132
2022 Q2	$203K	Buy	+1,631	New	+$194K	0.16%	127
2022 Q1	–	Sell	-1,631	Closed	-$206K	–	148
2021 Q4	$206K	Buy	+1,631	New	+$253K	0.16%	134

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MKT Advisors's IBB Position: Q1 2023 in Review

MKT Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 1,631 shares — an estimated $219K sold.

MKT Advisors first reported a position in IBB in Q4 2021 and held it in 3 quarters. The position peaked at $219K in Q4 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

MKT Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
MKT Advisors sold 1,631 iShares Biotechnology ETF shares in Q1 2023, an estimated $219K.
MKT Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 3 quarters.
MKT Advisors's iShares Biotechnology ETF position peaked at $219K in Q4 2022.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on MKT Advisors's 13F filing for Q1 2023, filed 10 Apr 2023.